No nancial bene t. ACC indicates American College of Cardiology; AHA, American Heart Association; DSMB, data safety monitoring board; and HRS, Heart Rhythm Society. Appendix 2. Reviewer Relationships With Industry and Other Entities (Relevant) 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia (March 2015) Reviewer Representation Employment Consultant Speakers Bureau Ownership/ Partnership/ Principal Personal Research Institutional, Organizational, or Other Financial Benefit Expert Witness Eugene H. Chung Official Reviewer HRS University of North Carolina School of Medicine Associate Professor of Medicine None None None None Zoll Medical None Timm L. Dickfeld Official Reviewer HRS University of Maryland School of Medicine Associate Professor of Medicine; Baltimore Veterans Affairs Medical Center Director, Electrophysiology Biosense Webster None None Biosense Webster* General Electric* None None Samuel S. Gidding Official Reviewer ACC/AHA Task Force on Clinical Practice Guidelines Nemours Cardiac Center Division Chief of Cardiology; Jefferson Medical College Professor of Pediatrics None None None None None None Richard J. Kovacs Official Reviewer ACC Board of Trustees Krannert Institute of Cardiology Professor of Clinical Medicine Biomedical Systems* None None Siemens AstraZeneca (DSMB) MED Institute* Eli Lilly (DSMB)* Teva Pharmaceuticals None Byron K. Lee Official Reviewer AHA University of California San Francisco Professor of Medicine Biotronik Boston Scientific St. Jude Medical None None Zoll Medical* CarioNet* Defendant, Boehringer Ingelheim, (Continued) Appendix 1. 